NAACCR Item #3809: AFP Pretreatment Interpretation
| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 3809 | 1 | NAACCR | 2018 | 18 |
NAACCR XML:
Tumor.afpPretreatmentInterpretation
Alternate Names
- AFP (Alpha Fetoprotein) Pretreatment Interpretation
Description
AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer.
Rationale
AFP (Alpha Fetoprotein) Pretreatment Interpretation is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1.
Codes
| 0 | Negative/normal; within normal limits |
| 1 | Positive/elevated |
| 2 | Borderline; undetermined if positive or negative |
| 7 | Test ordered, results not in chart |
| 8 | Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 8 will result in an edit error.) |
| 9 | Not documented in medical record AFP pretreatment interpretation not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.